ECUPHAR N V has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Hungary and Argentina. Its main competitors in its focus markets pharmaceuticals and measurement are DERMATECH LTD, SEINFELD HUGO and MEREO BIOPHARMA 2 LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Hungary | 2 | |
#3 | Argentina | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Mexico | 1 | |
#7 | Serbia | 1 | |
#8 | Taiwan | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Homedes-Beguer Josep | 8 |
#2 | Sabate-Elias David | 8 |
#3 | Sabate Elias David | 3 |
#4 | Homedes Beguer Josep M | 2 |
#5 | Josep Homedes Beguer | 1 |
#6 | Josep Homedes- Beguer | 1 |
#7 | Javier Lizcano Garcia | 1 |
#8 | Pedro Juan Solanas Ibarra | 1 |
#9 | David Sabate-Elias | 1 |
#10 | Antonio Lopez Cabrera | 1 |
Publication | Filing date | Title |
---|---|---|
EP3009137A1 | Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals |